Next Article in Journal
Skin Anti-Aging Potential of Ipomoea pes-caprae Ethanolic Extracts on Promoting Cell Proliferation and Collagen Production in Human Fibroblasts (CCD-986sk Cells)
Previous Article in Journal
Antibacterial, Antiparasitic, and Cytotoxic Activities of Chemical Characterized Essential Oil of Chrysopogon zizanioides Roots
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 15
Issue 8
10.3390/ph15080968
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Ag2O Nanoparticles as a Candidate for Antimicrobial Compounds of the New Generation

by
Sergey V. Gudkov
1,*,
Dmitriy A. Serov
1,
Maxim E. Astashev
1,
Anastasia A. Semenova
2 and
Andrey B. Lisitsyn
2
1
Prokhorov General Physics Institute of the Russian Academy of Sciences, 119991 Moscow, Russia
2
V. M. Gorbatov Federal Research Center for Food Systems of Russian Academy of Sciences, 109316 Moscow, Russia
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2022, 15(8), 968; https://doi.org/10.3390/ph15080968
Submission received: 13 July 2022 / Revised: 29 July 2022 / Accepted: 4 August 2022 / Published: 5 August 2022
(This article belongs to the Section Pharmaceutical Technology)
Browse Figures
Versions Notes

Abstract

:
Antibiotic resistance in microorganisms is an important problem of modern medicine which can be solved by searching for antimicrobial preparations of the new generation. Nanoparticles (NPs) of metals and their oxides are the most promising candidates for the role of such preparations. In the last few years, the number of studies devoted to the antimicrobial properties of silver oxide NPs have been actively growing. Although the total number of such studies is still not very high, it is quickly increasing. Advantages of silver oxide NPs are the relative easiness of production, low cost, high antibacterial and antifungal activities and low cytotoxicity to eukaryotic cells. This review intends to provide readers with the latest information about the antimicrobial properties of silver oxide NPs: sensitive organisms, mechanisms of action on microorganisms and further prospects for improving the antimicrobial properties.

1. Introduction

Since the moment of their discovery, antibiotics have been the “golden standard” in the treatment of many bacterial infections [1,2]. Unfortunately, the uncontrolled use of over-the-counter (OTC) antibiotics available without prescription has led to the emergence of new antibiotic-resistant bacterial strains. Diseases caused by such bacteria are not amenable to treatment. This phenomenon is called antibiotic resistance [3,4,5]. The development of antibiotic resistance in bacteria led to a new wave of growth in the number of infectious diseases and the necessity to search for new antimicrobial agents [6]. One of the ways to overcome antibiotic resistance in bacteria is the use of metal and metal oxide nanoparticles (NPs) [7]. Fungal diseases are a multi-national problem. More than 150 million people in the world have severe fungal diseases. More than 1.5 million cases of fungal diseases have a lethal outcome [8]. The problem is exacerbated by the development of fungal resistance to antifungal drugs [9]. There are reports about the antifungal properties of metal oxide NPs [10,11]. Since the beginning of the COVID-19 pandemic, special attention has been given to the search for inexpensive and effective antiviral agents [12,13].
The antimicrobial properties of silver and its compounds have been known since ancient times. The first references to the use of silver are dated back to 3500–1000 B.C. In particular, silver was used for dishware production and water storage; later on, there were attempts to use silver powder to treat various diseases [14,15,16]. It has been shown many times in the literature that nanoparticles (NPs) of silver and its compounds have significant bactericidal, fungicidal and antiviral activities [17,18,19]. Ag2O NPs have attracted particular attention of researchers in the field of nanomaterials because of their unique properties that ensure multiple functions and a wide field of application. The most significant applications of Ag2O NPs are the production of catalyzers, chemical sensors, optoelectronic devices and systems of targeted delivery of drugs in vivo [20,21,22,23,24]. Ag2O NPs also have significant antimicrobial potential [25,26,27]. Silver oxide is used as an antimicrobial agent in the creation of biocompatible materials when developing bone implants [28]. Biomedical applications also include cancer therapy, wound treatment, tissue protection from oxidative stress, therapy of stomach ulcer, etc. [29,30,31]. An important application at the interface of biomedicine and ecology is the use of Ag2O NPs for photocatalytic destruction of pharmaceutical micro-pollutants [32].
The aim of this review is to provide readers with methods for Ag2O NP production, a range of sensitive microorganisms, mechanisms of the antimicrobial activity and some ways for improving their antimicrobial properties.

2. Sensitive Microorganisms

There are data in the literature about the antimicrobial activity of Ag2O NPs against, at least, 53 microbial species (Table 1), including 21 species of Gram-negative bacteria, 15 species of Gram-positive bacteria and 17 fungal species (Figure 1a). Among the most often mentioned organisms are Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae; Gram-positive bacteria Staphylococcus aureus and Bacillus subtilis; and fungi Aspergillus and Candida albicans. All mentioned microorganisms have epidemiological significance. Antibiotic-resistant strains are most often found among Escherichia coli and Staphylococcus aureus [27,33,34,35,36]. We expected that the antimicrobial activity of Ag2O NPs against bacteria with different structures of cell wall (Gram-negative and Gram-positive) will greatly differ. An approximately equal amount (~20) of species of Gram-negative bacteria and Gram-positive bacteria sensitive to Ag2O NP was observed. This fact suggests the universality of the mechanisms of the antibacterial activity of Ag2O NPs. Ag2O NPs not only effectively inhibited bacterial growth, but also killed them. Therefore, Ag2O NPs are a perfect candidate for the role of a therapeutic agent against nosocomial bacterial infections [37].
When assessing a ratio of reports about the bactericidal and bacteriostatic activity of Ag2O NPs (Table 1), we found that bacteriostatic activity was described in about 75% of studies and bactericidal activity in 25% of studies. It is worth noting that the ratio of reports about the bactericidal and bacteriostatic activity of Ag2O NPs (equal to 1:3) is comparable to other widely used metal oxide NPs with antimicrobial activities, for example, iron oxides or ZnO NPs [7,88]. Iron oxides or ZnO NPs demonstrated high cytotoxicity in contradistinction to Ag2O NPs [89,90,91]. Having the same antimicrobial activity with other metal oxide NPs and low cytotoxicity makes Ag2O NPs an interesting candidate for the role of new generation antiseptic. For antifungal activities, the ratio shifted towards a reduction of the fungicidal activity. Only 15% of studies indicate the presence of the fungicidal effect and 85% contain data about the fungistatic effect. Therefore, fungi have higher resistance to Ag2O NPs compared to bacteria. This effect can be explained by the higher resistance of eukaryotic cells to the genotoxic effect of metal ions compared to prokaryotes, in particular, due to differences in the structure of the genetic apparatus and function of the reparation systems [92,93,94].

3. Synthesis Methods

Methods for the synthesis of Ag2O nanoparticles can be divided into physical, chemical and biological, otherwise referred to as “green synthesis” [95].
Chemical methods include various types of precipitation. The simplest method is realized when mixing AgNO3 with NaOH at high temperatures [13,58,75,96].
In this case, NP synthesis occurs in two stages described by the reaction equations:
AgNO3 + NaOH → AgOH + Na+ + NO3−
2AgOH → Ag2O + H2O (pK = 2.875)
Modifications of the method are possible: the addition of strong oxidizers, for example, K2S2O4, and KOH as a base [19,50]. Sometimes AgNO3 is obtained directly at the moment of synthesis upon the oxidation of silver foil with nitric acid; then, precipitation with alkali described above is performed [77]. To prevent the premature aggregation of synthesized Ag2O NPs, a surfactant—for example, citrate, polyethylene glycol, triethylene glycol, chitosan, urea and other compounds—can be added to the reaction mixture [40,82,96,97,98,99]. Another method for Ag2O NP production is the reduction of AgNO3 using organic acids citrate, acetate and oleic acid [45,53,56]. In the literature, this method is sometimes called the sol-gel method [100]. A method of Ag2O production upon the reduction of complex compounds, for example, ammoniate [Ag(NH3)2]x, is described [59,101]. To obtain NPs with a complex chemical composition, the drying of metal oxide NPs in the AgNO3 solution is used, as in the case of TiO2/Ag2O NPs [47].
The electrochemical synthesis (anode oxidation of metal silver) [102], precipitation upon ultrasound treatment [63], boiling [67,78], treatment with microwave radiation [22,78], evaporation of metal silver under the action of plasma [81] and laser ablation in water [52,53] can be assigned to physical methods.
Chemical and physical methods used today for NP synthesis can be expensive, require high temperatures and pressure or lead to the generation of waste that is hazardous for the environment [103]. Therefore, biological methods for the synthesis of nanomaterials, the so-called “green synthesis”, are preferable [26,104]. Moreover, silver oxide NPs obtained using biological methods have several advantages: low cost of synthesis, high antimicrobial activity, low cytotoxicity to mammalian cells and the possibility to use in pharmacology and biomedicine, like for NPs obtained by classical methods [105]. Similar to Ag NPs, “green” synthesis using extracts of medicinal plants is one of the methods for improving the antimicrobial properties of Ag2O NPs [106].
“Green synthesis” of Ag2O NPs consists of, as a rule, the reduction of water-soluble salt AgNO3 in an extract of medicinal plants or cultural liquid of non-pathogenic/weakly pathogenic microorganisms [107,108,109].
However, cases of real biosynthesis of Ag2O NPs are described, for example, synthesis by bacteria isolated from seeds of agricultural crops and cultivated in medium with the addition of AgNO3 [110,111] and soil bacteria Nitrobacter sp. [61]. In addition, methods for synthesis of Ag/Ag2O NPs by silver reduction in the medium of Fusarium oxysporum mycelium or dead biomass of yeasts [56,80] were described.

4. Methods for Studying Ag2O NPs

Dozens of methods have been applied to describe the parameters of Ag2O NPs. These methods are commonly used to study other Me/MexOy NPs [26]. To determine the size and shape of Ag2O NPs, various microscopic methods are used: atomic force microscopy (AFM) [112], scanning tunneling microscopy (STM) [113], scanning electron microscopy (SEM) [114] and transmission electron microscopy (TEM). The indicated methods allow us to image dry NPs and assess their size, shape, distribution on the surface of composite materials. To assess the elementary composition, proportion of organic impurities and conjugates, the following methods are used: UV–vis spectroscopy [115], Fourier transform infrared spectroscopy (FT-IR) [116,117], energy dispersive spectroscopy (EDX) [118], X-ray photoelectron spectroscopy (XPS) [119] and thermal gravimetric analysis (TGA) [120].
To determine the crystalline structure of NPs, the X-ray diffraction (XRD) method is applied [121,122]. To assess the hydrodynamic radius of NPs and stability of NP colloids in solvents, the dynamic light scattering (DLS) method and measurement of zeta potential, respectively, are used [123]. Assessment of the NP surface area and rheological properties of obtained nanomaterials is carried out by differential scanning calorimetry (DSC) and the Brunauer–Emmett–Teller (BET) method, respectively [124,125]. In the case of NP embedding into a polymeric material, it is possible to assess NP spatial distribution inside a polymeric matrix using modulation interference microscopy (MIM) [126].

5. Mechanisms of the Antimicrobial Activity

Antimicrobial properties of NPs are conditioned, first of all, by the antimicrobial properties of elements being their constituents. Silver ions show high toxicity to microorganisms. For example, Ag+ causes the death of Aspergillus niger spores at a concentration of 5.5 × 10−5 M (0.00006% w/w) and higher [127]. Ag NPs exert a significant antibacterial effect beginning from a concentration of 20 µg/mL [128,129]. It is shown that silver can be accumulated in microorganisms as Ag0, Ag2O or Ag+ [130]. Five mechanisms (as a minimum) of the antibacterial activity are described for these forms (Figure 2) [131].
The first mechanism is binding to the bacterial cell wall and disruption of the cell wall integrity, resulting in direct damage of the cell envelope and cytoplasmic components [96,97,100]. It is assumed that after Ag2O NP penetration into a bacterial cell, the release of Ag0 and/or Ag+ having the bactericidal activity according to the mechanisms described below takes place [132,133].
The second mechanisms of toxicity is binding to SH-groups of proteins with the subsequent disorder of their function [134]. Silver-induced inactivation of bacterial enzymes, in particular, dehydrogenases of the respiratory chain, is described [110]. This, in turn, inhibits ATP synthesis, disturbs the energy balance in cells, enhances an intracellular ROS production and causes oxidative stress [110,135]. Moreover, Ag2O NPs are able to release O2, which can also exert antibacterial activity [96].
The third mechanism is the oxidative stress described above. ROS cause protein modifications and exert a genotoxic effect [136,137,138]. An increase in ROS generation leads to the destruction of the cell wall and biofilms of both Gram-positive and Gram-negative bacteria [123].
The fourth mechanism of the antibacterial activity of Ag2O NPs is the genotoxic activity of Ag compounds, which after penetration inside a bacterial cell interact not only with proteins but also with phosphoric acid residues in DNA molecules [59,139].
It is assumed that silver compounds from Ag2O NPs and Ag NPs are also capable of binding to the N7 atom of guanine in DNA, therefore disturbing the process of its replication, inhibiting cell division [139].
The fifth mechanism is photocatalytic activity. The addition of Ag2O NPs can enhance the photocatalytic properties of other metal NPs. In particular, composites of Ag2O/TiO2 NPs and Ag2O/ZnO NPs demonstrate enhanced photocatalytic activity compared to TiO2 or ZnO NPs [140,141,142]. Furthermore, photocatalytic activity of Ag2O NPs was demonstrated. It is interesting that the photocatalytic activity of Ag2O NPs enhanced after the conjugation of Ag2O NPs with certain pharmaceutical agents, for example, moxifloxacin [48,62].
It is notable that Ag2O NPs possess high toxicity to pathogenic microorganisms and low toxicity to soil microorganisms. In particular, soil Nitrobacter sp., Bacillus sp. and Pseudomonas strains are able to synthesize Ag2O NPs from AgNO3 in amounts sufficient for the growth inhibition of pathogenic microorganisms of the human oral cavity [49,54,61,78,143]. Specific Ag2O NP cytotoxicity to pathogenic microorganisms is an attractive feature for the creation of eco-friendly antimicrobial materials and preparations.

6. Methods for Improving Antimicrobial Properties

In meta-analysis, we found a dependence of the bacteriostatic activity (expressed in MIC) on NP size (Figure 1b). When a NP’s size decreases, an increase in its toxicity to microbes is observed. This dependence corresponds to the literature data about NPs of other metal oxides [7,144], and can be explained by a growth in the release of Ag+, Ag0 and Ag2O from NPs into the surrounding solution due to an increase in the area to volume ratio.
Antimicrobial properties of Ag2O NPs can be improved at the initial stage of NP synthesis: precipitation of Ag2O NPs. For example, precipitation of Ag2O NPs in medium with low (10 mM) or high (100 mM) concentration of AgNO3 lead to obtaining cubic or octahedral Ag2O NPs, respectively [74]. Cubic Ag2O NPs showed more pronounced bacteriostatic effects compared to octahedral [74].
The most common other modifications of Ag2O NP synthesis are NP coating with polymers, Ag2O NP inclusion into other nanocomposites or fusion with NPs of oxides of other elements and NP synthesis in the medium of a substrate of the biological origin—most often an extract of plant leaves (Figure 1c) [34,47,118].
Coatings can be conditionally divided into two large groups. The first group includes organic polymers: chitosan, polyethersulfone, cellulose acetate, polyvinyl alcohol, polyethylene terephthalate and starch [41,42,43,57,96]. This modification commonly had bacteriostatic and fungistatic activity [39,43]. Pharmaceutical preparations, in particular, aspirin and moxifloxacin, can be assigned to the second group [43,62]. For example, Ag2O NP coating with aspirin increased their bacteriostatic and fungistatic activity by 50% compared to non-conjugated NPs. In the case of Ag2O NP conjugation with moxifloxacin, a more pronounced increase in the bacteriostatic and fungistatic activity of Ag2O NPs (by 2–3 times) was shown [62]. Ag2O NP coating with chitosan allows practically 100% inhibition of the bacterial growth to be achieved irrespective of their Gram stain group [40]. An opportunity to use conjugates chitosan/Ag2O NPs for the creation of fabrics and cloths with the bacteriostatic properties is shown [40,41].
Examples of nanocomposites with Ag2O NPs are relatively rare. Among them, composites with ZrO2, TiO2 NPs, H2Ti3O7·2H2O and graphene oxide can be highlighted [60,122,123]. The addition of graphene oxide resulted in a dose-dependent increase in the antibacterial properties of Ag2O NPs. It is notable that in the case of graphene oxide, an enhancement of the bacteriostatic properties against Gram-negative bacteria was more pronounced [46].
The most common modification of Ag2O NP synthesis is the so-called “green synthesis”. There are reports about the use of extracts of plants Abroma augusta, Lawsonia inermis, Ficus benghal, Lippia citriodora, Eupatorium odoratum, Cleome gynandra, Aloe vera, Vaccinium arctostaphylos, Coleus aromaticus, Rhamnus virgate, Cyathea nilgiriensis, Centella Asiatica, Tridax sp., Hylocereus undatus, Paeonia emodi, Pinus longifolia and Telfairia occidentalis Telfairia occidentalis [33,34,35,36,37,51,60,64,65,66,69,73,76,83,84,85]; fungi Fusarium oxysporum, Kitasatospora albolonga, Rhodotorula mucilaginosa and Aspergillus terreus VIT 2013 [27,78,79,135]; and culture media of bacteria Bacillus paramycoides, Bacillus thuringiensis SSV1, Nitrobacter sp. (strain NCIM 5067) and Pseudomonas aeruginosa M6 [63,77,113,114]. “Green synthesis” enables Ag/Ag2O NPs to be obtained from wastes of silver mines, which may increase the production of silver mines and decrease environmental pollution [145]. “Green synthesized” Ag2O NP had not only bacteriostatic activity, but also fungicidal activity [37,79,125].
It is worth noting that all modifications of Ag2O NP synthesis enhance their antimicrobial properties compared to the chemical synthesis methods, in particular, precipitation (Figure 1c). Therefore, the selection of the conditions of Ag2O NP synthesis can make it possible to obtain NPs with high antimicrobial activity against antibiotic resistance bacteria. There are data that show that a synergetic effect is possible due to the use of several methods to improve the bacteriostatic activity of Ag2O NPs [75], for example, the synthesis of complex composites Cu·PES/CA/Ag2O NPs. This composite had more pronounced bacteriostatic properties compared to PES/CA/Ag2O NPs [42].
A growth in the studies devoted to the creation of various composites with the addition of Ag/Ag2O NPs (Table 1) allows us to suggest that the development of new composite materials with Ag2O NP introduction and, as a consequence, the extension of application fields for Ag2O NP-based nanomaterials will be promising investigations in this field [60,118,122,123].

7. Cytotoxicity to Human Cells

Data on Ag2O NP cytotoxicity are ambiguous and constantly being enriched. There are data about the toxicity of Ag2O NPs/Aspergillus terreus to Dalton’s lymphoma ascites (DLA) cells, which enables the use of Ag2O NPs in the therapy of oncological diseases [36]. High cytotoxicity of Ag2O/Ag NPs reported against breast cancer cell line MCF-7 and lung cancer cell line A549. Mechanisms of toxicity are genotoxic effects and ROS overproduction and membrane disruption [146]. Cytotoxicity of Ag NPs and consequently Ag2O NPs against eukaryotic cells is actively studied. Induction of apoptosis and necrosis by Ag2O/Ag NPs was shown on lung cells lines A549, MRC-5, bronchial cells BEAS-2B and NIH3T3, 3D-cultures of human primary small airway epithelial cell, etc. [147,148,149,150,151]. The ways to increase the cytotoxicity of Ag NPs against cancer and decrease against normal cells have been researched [152]. An interesting approach is using different coating agents; for example, Ag NP cytotoxicity increases in range “PVP > citrate > plant extracts > without coating”, but in the case of PVP and citrate, increased predominantly anticancer activity [153].
However, many studies report the low cytotoxicity of Ag2O NPs to eukaryotic cells. For example, Ag2O NPs did not affect the survival and migration of 3T3 fibroblast cells [63]. It was shown for Ag/Ag2O NPs/R. mucilaginosa that the cytotoxic action against eukaryotic cells was realized at concentrations 4–10 times higher than the cytotoxic action against bacteria and fungi [80]. For nanocomposites based on borosiloxane and PLGA and Ag2O NPs, the high bactericidal activity was found at Ag2O NP concentrations from 1 μg/ml; with that, the survival and the proliferation rate of eukaryotic cells on the above mentioned composites was comparable to these parameters obtained on the culture plastic [52,53]. Low cytotoxicity allows Ag2O NPs to be used for wound healing [37].
We assume that the cause of high biocompatibility with eukaryotic cells in the majority of studies is the use of Ag2O NP conjugates and composites instead of “pure” Ag2O NPs. We also proposed that Ag2O is more biologically invert compared to pure Ag.
Metal oxide NPs were potential drug delivery systems. The moderate/low cytotoxicity of Ag2O/Ag NPs makes them a perfect candidate for drug delivery systems [154,155,156]. Ag2O/Ag NPs can be used in anticancer and antiviral therapy [157,158,159]. Ag2O/Ag NPs can also be used as a photoactivated drug delivery unit, for example, in the localized induction of bone regeneration [160].

8. Conclusions

A search for antimicrobial agents of the new generation that allow us to overcome bacterial antibiotic resistance is an important task for world public health. Candidates for such agents are Ag2O NPs. Over the last three years, the interest of researchers in Ag2O NPs has increased manifold. The reason for this is the high toxicity to Gram-positive and Gram-negative bacteria, including antibiotic resistance, as well as fungi having epidemiological significance. Moreover, Ag2O NPs are inexpensive and easy to produce, and the field of their possible application includes regenerative medicine, prosthetics, therapy of oncological diseases, as well as the development of a wide spectrum of materials with antimicrobial properties (textile and construction). Ag2O NP cytotoxicity to eukaryotic cells and nonpathogenic microorganisms is significantly lower than against human pathogens, which makes Ag2O NPs an attractive candidate for the role of an antimicrobial agent safe for humans and the environment. Extension of the list of composite materials with the addition of Ag2O NPs and, as a consequence, an increase in the number of application fields for Ag2O NP-based nanomaterials can be considered the expected outcomes of investigations in this field.

Author Contributions

Conceptualization, S.V.G. and D.A.S.; writing—original draft preparation, S.V.G. and D.A.S.; writing—review and editing S.V.G. and A.A.S.; visualization, D.A.S. and M.E.A.; funding acquisition, A.B.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Ministry of Science and Education of the Russian Federation (Grant Agreement 075-15-2020-775).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable.

Acknowledgments

The authors are grateful to the Center for the collective use of the GPI RAS and to the heavy metal band Aria for what they are.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Davies, J.; Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 2010, 74, 417–433. [Google Scholar] [CrossRef] [PubMed]
  2. Cavalieri, F.; Tortora, M.; Stringaro, A.; Colone, M.; Baldassarri, L. Nanomedicines for antimicrobial interventions. J. Hosp. Infect. 2014, 88, 183–190. [Google Scholar] [CrossRef] [PubMed]
  3. Devi, L.S.; Joshi, S.R. Evaluation of the antimicrobial potency of silver nanoparticles biosynthesized by using an endophytic fungus Cryptosporiopsis ericae PS4. J. Microbiol. 2014, 52, 667–674. [Google Scholar] [CrossRef] [PubMed]
  4. Almatar, M.; Makky, E.A.; Var, I.; Koksal, F. The role of nanoparticles in the inhibition of multidrug-resistant bacteria and biofilms. Curr. Drug Deliv. 2018, 15, 470–484. [Google Scholar] [CrossRef]
  5. Solberg, C.O. Spread of Staphylococcus aureus in Hospitals: Causes and Prevention. Scand. J. Infect. Dis. 2000, 32, 587–595. [Google Scholar] [CrossRef]
  6. Gajbhiye, M.; Kesharwani, J.; Ingle, A.; Gade, A.; Rai, M. Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomed. Nanotechnol. Biol. Med. 2009, 5, 382–386. [Google Scholar] [CrossRef]
  7. Gudkov, S.V.; Burmistrov, D.E.; Serov, D.A.; Rebezov, M.B.; Semenova, A.A.; Lisitsyn, A.B. A Mini Review of Antibacterial Properties of ZnO Nanoparticles. Front. Phys. 2021, 9, 641481. [Google Scholar] [CrossRef]
  8. Bongomin, F.; Gago, S.; Oladele, R.O.; Denning, D.W. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. J. Fungi 2017, 3, 57. [Google Scholar] [CrossRef]
  9. Ben-Ami, R.; Kontoyiannis, D.P. Resistance to Antifungal Drugs. Infect. Dis. Clin. N. Am. 2021, 35, 279–311. [Google Scholar] [CrossRef]
  10. Du, W.; Gao, Y.; Liu, L.; Sai, S.; Ding, C. Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies. Int. J. Mol. Sci. 2021, 22, 10104. [Google Scholar] [CrossRef]
  11. Khalil, N.M.; Abd El-Ghany, M.N.; Rodríguez-Couto, S. Antifungal and anti-mycotoxin efficacy of biogenic silver nanoparticles produced by Fusarium chlamydosporum and Penicillium chrysogenum at non-cytotoxic doses. Chemosphere 2019, 218, 477–486. [Google Scholar] [CrossRef]
  12. Coutard, B.; Valle, C.; De Lamballerie, X.; Canard, B.; Seidah, N.; Decroly, E. The Spike Glycoprotein of The New Coronavirus 2019-nCoV Contains A Furin-Like Cleavage Site Absent in Cov of The Same Clade. Antivir. Res. 2020, 176, 104742. [Google Scholar] [CrossRef]
  13. Hosseini, M.; Chin, A.W.H.; Williams, M.D.; Behzadinasab, S.; Falkinham, J.O.; Poon, L.L.M.; Ducker, W.A. Transparent Anti-SARS-CoV-2 and Antibacterial Silver Oxide Coatings. ACS Appl. Mater. Interfaces 2022, 14, 8718–8727. [Google Scholar] [CrossRef]
  14. Fong, J. The use of silver products in the management of burn wounds: Change in practice for the burn unit at Royal Perth Hospital. Prim. Intent. Aust. J. Wound Manag. 2005, 13, 16–22. [Google Scholar]
  15. Russell, F.R.; Pathm, W.B.; Hugo, A.D. Antimicrobial activity and action of silver. Prog. Med. Chem. 1994, 31, 351–371. [Google Scholar] [CrossRef]
  16. Uttayarat, P.; Eamsiri, J.; Tangthong, T.; Suwanmala, P. Radiolytic synthesis of colloidal silver nanoparticles for antibacterial wound dressings. Adv. Mater. Sci. Eng. 2015, 2015, 376082. [Google Scholar] [CrossRef]
  17. Kim, J.S.; Kuk, E.; Yu, K.N.; Kim, J.H.; Park, S.J.; Lee, H.J.; Kim, S.H.; Park, Y.K.; Park, Y.H.; Hwang, C.Y.; et al. Antimicrobial effects of silver nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2007, 3, 95–101. [Google Scholar] [CrossRef]
  18. Chen, X.; Schluesener, H.J. Nanosilver: A nanoproduct in medical application. Toxicol. Lett. 2008, 176, 1–12. [Google Scholar] [CrossRef]
  19. Shen, W.; Li, P.; Feng, H.; Ge, Y.; Liu, Z.; Feng, L. The bactericidal mechanism of action against Staphylococcus aureus for AgO nanoparticles. Mater. Sci. Eng. C Mater. Biol. Appl. 2017, 75, 610–619. [Google Scholar] [CrossRef]
  20. Jain, S.; Mehata, M.S. Medicinal Plant Leaf Extract and Pure Flavonoid Mediated Green Synthesis of Silver Nanoparticles and their Enhanced Antibacterial Property. Sci. Rep. 2017, 7, 15867. [Google Scholar] [CrossRef]
  21. Ravichandran, S.; Paluri, V.; Kumar, G.; Loganathan, K.; Kokati Venkata, B.R. A novel approach for the biosynthesis of silver oxide nanoparticles using aqueous leaf extract of Callistemon lanceolatus (Myrtaceae) and their therapeutic potential. J. Exp. Nanosci. 2016, 11, 445–458. [Google Scholar] [CrossRef]
  22. Chakraborty, U.; Garg, P.; Bhanjana, G.; Kaur, G.; Kaushik, A.; Chaudhary, G.R. Spherical silver oxide nanoparticles for fabrication of electrochemical sensor for efficient 4-Nitrotoluene detection and assessment of their antimicrobial activity. Sci. Total Environ. 2022, 808, 152179. [Google Scholar] [CrossRef]
  23. Rahman, M.; Khan, S.; Jamal, A.; Faisal, M.; Asiri, A.M. Highly Sensitive Methanol Chemical Sensor Based on Undoped Silver Oxide Nanoparticles Prepared by a Solution Method. Microchim. Acta 2012, 178, 99–106. [Google Scholar] [CrossRef]
  24. Zhou, X.; Lu, Y.; Zhai, L.-L.; Zhao, Y.; Liu, Q.; Sun, W.-Y. Propargylamines formed from three-component coupling reactions catalyzed by silver oxide nanoparticles. RSC Adv. 2013, 3, 1732–1734. [Google Scholar] [CrossRef]
  25. Konop, M.; Damps, T.; Misicka, A.; Rudnicka, L. Certain Aspects of Silver and Silver Nanoparticles in Wound Care: A Minireview. J. Nanomater. 2016, 2016, 7614753. [Google Scholar] [CrossRef]
  26. Ghotekar, S.; Dabhane, H.; Pansambal, S.; Oza, R.; Tambade, P.; Medhane, V. A Review on Biomimetic Synthesis of Ag2O Nanoparticles using Plant Extract, Characterization and its Recent Applications. Adv. J. Chem. Sect. B 2020, 2, 102–111. [Google Scholar] [CrossRef]
  27. Sangappa, M.; Thiagarajan, P. Combating drug resistant pathogenic bacteria isolated from clinical infections, with silver oxide nanoparticles. Indian J. Pharm. Sci. 2015, 77, 151–155. [Google Scholar] [CrossRef]
  28. Ni, S.; Li, X.; Yang, P.; Ni, S.; Hong, F.; Webster, T.J. Enhanced apatite-forming ability and antibacterial activity of porous anodic alumina embedded with CaO-SiO2-Ag2O bioactive materials. Mater. Sci. Eng. C Mater. Biol. Appl. 2016, 58, 700–708. [Google Scholar] [CrossRef]
  29. Borges Rosa De Moura, F.; Antonio Ferreira, B.; Helena Muniz, E.; Benatti Justino, A.; Gabriela Silva, A.; De Azambuja Ribeiro, R.I.M.; Oliveira Dantas, N.; Lisboa Ribeiro, D.; De Assis Araújo, F.; Salmen Espindola, F.; et al. Antioxidant, anti-inflammatory, and wound healing effects of topical silver-doped zinc oxide and silver oxide nanocomposites. Int. J. Pharm. 2022, 617, 121620. [Google Scholar] [CrossRef]
  30. Iqbal, S.; Fakhar-E-Alam, M.; Akbar, F.; Shafiq, M.; Atif, M.; Amin, N.; Ismail, M.; Hanif, A.; Farooq, W.A. Application of silver oxide nanoparticles for the treatment of cancer. J. Mol. Struct. 2019, 1189, 203–209. [Google Scholar] [CrossRef]
  31. Salem, N.A.; Wahba, M.A.; Eisa, W.H.; El-Shamarka, M.; Khalil, W. Silver oxide nanoparticles alleviate indomethacin-induced gastric injury: A novel antiulcer agent. Inflammopharmacology 2018, 26, 1025–1035. [Google Scholar] [CrossRef] [PubMed]
  32. Pu, S.; Yang, Z.; Tang, J.; Ma, H.; Xue, S.; Bai, Y. Plasmonic silver/silver oxide nanoparticles anchored bismuth vanadate as a novel visible-light ternary photocatalyst for degrading pharmaceutical micropollutants. J. Environ. Sci. 2020, 96, 21–32. [Google Scholar] [CrossRef] [PubMed]
  33. Abbasi, B.A.; Iqbal, J.; Nasir, J.A.; Zahra, S.A.; Shahbaz, A.; Uddin, S.; Hameed, S.; Gul, F.; Kanwal, S.; Mahmood, T. Environmentally friendly green approach for the fabrication of silver oxide nanoparticles: Characterization and diverse biomedical applications. Microsc. Res. Tech. 2020, 83, 1308–1320. [Google Scholar] [CrossRef] [PubMed]
  34. Khatun, Z.; Lawrence, R.S.; Jalees, M.; Lawerence, K. Green synthesis and Anti-bacterial activity of Silver Oxide nanoparticles prepared from Pinus longifolia leaves extract. Int. J. Adv. Res. 2015, 3, 337–343. [Google Scholar]
  35. Shah, A.; Haq, S.; Rehman, W.; Waseem, M.; Shoukat, S.; Rehman, M.-U. Photocatalytic and antibacterial activities of paeonia emodi mediated silver oxide nanoparticles. Mater. Res. Express 2019, 6, 045045. [Google Scholar] [CrossRef]
  36. Pradheesh, G.; Suresh, S.; Suresh, J.; Alexramani, V. Antimicrobial and anticancer activity studies on green synthesized silver oxide nanoparticles from the medicinal plant cyathea nilgiriensis holttum. Int. J. Pharm. Investig. 2020, 10, 146–150. [Google Scholar] [CrossRef]
  37. Roy, A.; Srivastava, S.K.; Shrivastava, S.L.; Mandal, A.K. Hierarchical Assembly of Nanodimensional Silver–Silver Oxide Physical Gels Controlling Nosocomial Infections. ACS Omega 2020, 5, 32617–32631. [Google Scholar] [CrossRef]
  38. Jin, Y.; Dong, S. One-Pot Synthesis and Characterization of Novel Silver−Gold Bimetallic Nanostructures with Hollow Interiors and Bearing Nanospikes. J. Phys. Chem. B 2003, 107, 12902–12905. [Google Scholar] [CrossRef]
  39. Tripathi, S.; Mehrotra, G.K.; Dutta, P.K. Chitosan–silver oxide nanocomposite film: Preparation and antimicrobial activity. Bull. Mater. Sci. 2011, 34, 29–35. [Google Scholar] [CrossRef]
  40. Hu, Z.; Zhang, J.; Chan, W.L.; Szeto, Y.S. Suspension of Silver Oxide Nanoparticles in Chitosan Solution and its Antibacterial Activity in Cotton Fabrics. MRS Online Proc. Libr. 2006, 920, 203. [Google Scholar] [CrossRef]
  41. Hu, Z.; Chan, W.L.; Szeto, Y.S. Nanocomposite of chitosan and silver oxide and its antibacterial property. J. Appl. Polym. Sci. 2008, 108, 52–56. [Google Scholar] [CrossRef]
  42. Gul, S.; Rehan, Z.A.; Khan, S.A.; Akhtar, K.; Khan, M.A.; Khan, M.I.; Rashid, M.I.; Asiri, A.M.; Khan, S.B. Antibacterial PES-CA-Ag2O nanocomposite supported Cu nanoparticles membrane toward ultrafiltration, BSA rejection and reduction of nitrophenol. J. Mol. Liq. 2017, 230, 616–624. [Google Scholar] [CrossRef]
  43. Kakakhel, S.A.; Rashid, H.; Jalil, Q.; Munir, S.; Barkatullah, B.; Khan, S.; Ullah, R.; Shahat, A.; Mahmood, H.; A-Mishari, A.; et al. Polymers Encapsulated Aspirin Loaded Silver Oxide Nanoparticles: Synthesis, Characterization and its Bio-Applications. Sains Malays. 2019, 48, 1887–1897. [Google Scholar] [CrossRef]
  44. Aazem, I.; Rathinam, P.; Pillai, S.; Honey, G.; Vengellur, A.; Bhat, S.G.; Sailaja, G.S. Active bayerite underpinned Ag2O/Ag: An efficient antibacterial nanohybrid combating microbial contamination. Metallomics 2021, 13, mfab049. [Google Scholar] [CrossRef]
  45. Sajjad, S.; Arshad, F.; Uzair, B.; Leghari, S.A.K.; Noor, S.; Maaza, M. GO/Ag2O Composite Nanostructure as an Effective Antibacterial Agent. ChemistrySelect 2019, 4, 10365–10371. [Google Scholar] [CrossRef]
  46. Rajabi, A.; Ghazali, M.J.; Mahmoudi, E.; Baghdadi, A.H.; Mohammad, A.W.; Mustafah, N.M.; Ohnmar, H.; Naicker, A.S. Synthesis, Characterization, and Antibacterial Activity of Ag₂O-Loaded Polyethylene Terephthalate Fabric via Ultrasonic Method. Nanomaterials 2019, 9, 450. [Google Scholar] [CrossRef]
  47. Sboui, M.; Lachheb, H.; Bouattour, S.; Gruttadauria, M.; La Parola, V.; Liotta, L.F.; Boufi, S. TiO2/Ag2O immobilized on cellulose paper: A new floating system for enhanced photocatalytic and antibacterial activities. Environ. Res. 2021, 198, 111257. [Google Scholar] [CrossRef]
  48. Lin, Z.; Lu, Y.; Huang, J. A hierarchical Ag2O-nanoparticle/TiO2-nanotube composite derived from natural cellulose substance with enhanced photocatalytic performance. Cellulose 2019, 26, 6683–6700. [Google Scholar] [CrossRef]
  49. Dharmaraj, D.; Krishnamoorthy, M.; Rajendran, K.; Karuppiah, K.; Annamalai, J.; Durairaj, K.R.; Santhiyagu, P.; Ethiraj, K. Antibacterial and cytotoxicity activities of biosynthesized silver oxide (Ag2O) nanoparticles using Bacillus paramycoides. J. Drug Deliv. Sci. Technol. 2021, 61, 102111. [Google Scholar] [CrossRef]
  50. Li, D.; Chen, S.; Zhang, K.; Gao, N.; Zhang, M.; Albasher, G.; Shi, J.; Wang, C. The interaction of Ag2O nanoparticles with Escherichia coli: Inhibition–sterilization process. Sci. Rep. 2021, 11, 1703. [Google Scholar] [CrossRef]
  51. Fayyadh, A.A.; Jaduaa Alzubaidy, M.H. Green-synthesis of Ag2O nanoparticles for antimicrobial assays**. J. Mech. Behav. Mater. 2021, 30, 228–236. [Google Scholar] [CrossRef]
  52. Chausov, D.N.; Smirnova, V.V.; Burmistrov, D.E.; Sarimov, R.M.; Kurilov, A.D.; Astashev, M.E.; Uvarov, O.V.; Dubinin, M.V.; Kozlov, V.A.; Vedunova, M.V.; et al. Synthesis of a Novel, Biocompatible and Bacteriostatic Borosiloxane Composition with Silver Oxide Nanoparticles. Materials 2022, 15, 2. [Google Scholar] [CrossRef]
  53. Smirnova, V.V.; Chausov, D.N.; Serov, D.A.; Kozlov, V.A.; Ivashkin, P.I.; Pishchalnikov, R.Y.; Uvarov, O.V.; Vedunova, M.V.; Semenova, A.A.; Lisitsyn, A.B.; et al. A Novel Biodegradable Composite Polymer Material Based on PLGA and Silver Oxide Nanoparticles with Unique Physicochemical Properties and Biocompatibility with Mammalian Cells. Materials 2021, 14, 22. [Google Scholar] [CrossRef]
  54. Karunagaran, V.; Rajendran, K.; Sen, S. Antimicrobial Activity of Biosynthesized Silver Oxide Nanoparticles. J. Pure Appl. Microbiol. 2014, 4, 3263–3268. [Google Scholar]
  55. Ayanwale, A.P.; Ruíz-Baltazar, A.D.J.; Espinoza-Cristóbal, L.; Reyes-López, S.Y. Bactericidal Activity Study of ZrO2-Ag2O Nanoparticles. Dose-Response 2020, 18, 1559325820941374. [Google Scholar] [CrossRef]
  56. Islam, S.N.; Naqvi, S.M.A.; Parveen, S.; Ahmad, A. Application of mycogenic silver/silver oxide nanoparticles in electrochemical glucose sensing; alongside their catalytic and antimicrobial activity. 3 Biotech 2021, 11, 342. [Google Scholar] [CrossRef]
  57. Rokade, A.A.; Patil, M.P.; Yoo, S.I.; Lee, W.K.; Park, S.S. Pure green chemical approach for synthesis of Ag2O nanoparticles. Green Chem. Lett. Rev. 2016, 9, 216–222. [Google Scholar] [CrossRef]
  58. Shaffiey, S.R.; Shaffiey, S. Synthesis and evaluation of bactericidal properties of Ag2O nanoparticles against Aeromonashydrophila. Int. J. Nano Dimens. 2014, 6, 263–269. [Google Scholar] [CrossRef]
  59. Panáček, A.; Kvítek, L.; Prucek, R.; Kolář, M.; Večeřová, R.; Pizúrová, N.; Sharma, V.K.; Nevěčná, T.J.; Zbořil, R. Silver Colloid Nanoparticles:  Synthesis, Characterization, and Their Antibacterial Activity. J. Phys. Chem. B 2006, 110, 16248–16253. [Google Scholar] [CrossRef]
  60. Manikandan, V.; Velmurugan, P.; Park, J.H.; Chang, W.S.; Park, Y.J.; Jayanthi, P.; Cho, M.; Oh, B.T. Green synthesis of silver oxide nanoparticles and its antibacterial activity against dental pathogens. 3 Biotech 2017, 7, 72. [Google Scholar] [CrossRef]
  61. Karunakaran, G.; Jagathambal, M.; Gusev, A.; Minh, N.V.; Kolesnikov, E.; Mandal, A.R.; Kuznetsov, D. Nitrobacter sp. extract mediated biosynthesis of Ag(2)O NPs with excellent antioxidant and antibacterial potential for biomedical application. IET Nanobiotechnol. 2016, 10, 425–430. [Google Scholar] [CrossRef] [PubMed]
  62. Haq, S.; Rehman, W.; Waseem, M.; Meynen, V.; Awan, S.U.; Saeed, S.; Iqbal, N. Fabrication of pure and moxifloxacin functionalized silver oxide nanoparticles for photocatalytic and antimicrobial activity. J. Photochem. Photobiol. B Biol. 2018, 186, 116–124. [Google Scholar] [CrossRef] [PubMed]
  63. Babu, P.J.; Doble, M.; Raichur, A.M. Silver oxide nanoparticles embedded silk fibroin spuns: Microwave mediated preparation, characterization and their synergistic wound healing and anti-bacterial activity. J. Colloid Interface Sci. 2018, 513, 62–71. [Google Scholar] [CrossRef] [PubMed]
  64. Li, R.; Chen, Z.; Ren, N.; Wang, Y.; Wang, Y.; Yu, F. Biosynthesis of silver oxide nanoparticles and their photocatalytic and antimicrobial activity evaluation for wound healing applications in nursing care. J. Photochem. Photobiol. B Biol. 2019, 199, 111593. [Google Scholar] [CrossRef]
  65. Elemike, E.E.; Onwudiwe, D.C.; Ekennia, A.C.; Sonde, C.U.; Ehiri, R.C. Green Synthesis of Ag/Ag₂O Nanoparticles Using Aqueous Leaf Extract of Eupatorium odoratum and Its Antimicrobial and Mosquito Larvicidal Activities. Molecules 2017, 22, 674. [Google Scholar] [CrossRef]
  66. Mani, M.; Harikrishnan, R.; Purushothaman, P.; Pavithra, S.; Rajkumar, P.; Kumaresan, S.; Al Farraj, D.A.; Elshikh, M.S.; Balasubramanian, B.; Kaviyarasu, K. Systematic green synthesis of silver oxide nanoparticles for antimicrobial activity. Environ. Res. 2021, 202, 111627. [Google Scholar] [CrossRef]
  67. Hoque, M.I.U.; Chowdhury, A.N.; Islam, M.T.; Firoz, S.H.; Luba, U.; Alowasheeir, A.; Rahman, M.M.; Rehman, A.U.; Ahmad, S.H.A.; Holze, R.; et al. Fabrication of highly and poorly oxidized silver oxide/silver/tin(IV) oxide nanocomposites and their comparative anti-pathogenic properties towards hazardous food pathogens. J. Hazard. Mater. 2021, 408, 124896. [Google Scholar] [CrossRef]
  68. Negi, H.; Rathinavelu Saravanan, P.; Agarwal, T.; Ghulam Haider Zaidi, M.; Goel, R. In vitro assessment of Ag2O nanoparticles toxicity against Gram-positive and Gram-negative bacteria. J. Gen. Appl. Microbiol. 2013, 59, 83–88. [Google Scholar] [CrossRef]
  69. Flores-Lopez, N.S.; Cervantes-Chávez, J.A.; Téllez De Jesús, D.G.; Cortez-Valadez, M.; Estévez-González, M.; Esparza, R. Bactericidal and fungicidal capacity of Ag(2)O/Ag nanoparticles synthesized with Aloe vera extract. J. Environ. Sci. Health. Part A Toxic/Hazard. Subst. Environ. Eng. 2021, 56, 762–768. [Google Scholar] [CrossRef]
  70. Chen, Y.; Gao, A.; Bai, L.; Wang, Y.; Wang, X.; Zhang, X.; Huang, X.; Hang, R.; Tang, B.; Chu, P.K. Antibacterial, osteogenic, and angiogenic activities of SrTiO(3) nanotubes embedded with Ag(2)O nanoparticles. Mater. Sci. Eng. C Mater. Biol. Appl. 2017, 75, 1049–1058. [Google Scholar] [CrossRef]
  71. Jin, Y.; Dai, Z.; Liu, F.; Kim, H.; Tong, M.; Hou, Y. Bactericidal mechanisms of Ag₂O/TNBs under both dark and light conditions. Water Res. 2013, 47, 1837–1847. [Google Scholar] [CrossRef]
  72. Gao, A.; Hang, R.; Huang, X.; Zhao, L.; Zhang, X.; Wang, L.; Tang, B.; Ma, S.; Chu, P.K. The effects of titania nanotubes with embedded silver oxide nanoparticles on bacteria and osteoblasts. Biomaterials 2014, 35, 4223–4235. [Google Scholar] [CrossRef]
  73. Khodadadi, S.; Mahdinezhad, N.; Fazeli-Nasab, B.; Heidari, M.J.; Fakheri, B.; Miri, A. Investigating the Possibility of Green Synthesis of Silver Nanoparticles Using Vaccinium arctostaphlyos Extract and Evaluating Its Antibacterial Properties. BioMed Res. Int. 2021, 2021, 5572252. [Google Scholar] [CrossRef]
  74. Wang, X.; Wu, H.F.; Kuang, Q.; Huang, R.B.; Xie, Z.X.; Zheng, L.S. Shape-dependent antibacterial activities of Ag2O polyhedral particles. Langmuir ACS J. Surf. Colloids 2010, 26, 2774–2778. [Google Scholar] [CrossRef]
  75. Kundu, S.; Sain, S.; Choudhury, P.; Sarkar, S.; Das, P.K.; Pradhan, S.K. Microstructure characterization of biocompatible heterojunction hydrogen titanate-Ag(2)O nanocomposites for superior visible light photocatalysis and antibacterial activity. Mater. Sci. Eng. C Mater. Biol. Appl. 2019, 99, 374–386. [Google Scholar] [CrossRef]
  76. Lekshmi, G.S.; Tamilselvi, R.; Geethalakshmi, R.; Kirupha, S.D.; Bazaka, O.; Levchenko, I.; Bazaka, K.; Mandhakini, M. Multifunctional oil-produced reduced graphene oxide - Silver oxide composites with photocatalytic, antioxidant, and antibacterial activities. J. Colloid Interface Sci. 2022, 608, 294–305. [Google Scholar] [CrossRef]
  77. Sajjad, S.; Uzair, B.; Shaukat, A.; Jamshed, M.; Leghari, S.A.K.; Ismail, M.; Mansoor, Q. Synergistic evaluation of AgO(2) nanoparticles with ceftriaxone against CTXM and blaSHV genes positive ESBL producing clinical strains of Uro-pathogenic E. coli. IET Nanobiotechnol. 2019, 13, 435–440. [Google Scholar] [CrossRef]
  78. Boopathi, S.; Gopinath, S.; Boopathi, T.; Balamurugan, V.; Rajeshkumar, R.; Sundararaman, M. Characterization and Antimicrobial Properties of Silver and Silver Oxide Nanoparticles Synthesized by Cell-Free Extract of a Mangrove-Associated Pseudomonas aeruginosa M6 Using Two Different Thermal Treatments. Ind. Eng. Chem. Res. 2012, 51, 5976–5985. [Google Scholar] [CrossRef]
  79. D’lima, L.; Phadke, M.; Ashok, V.D. Biogenic silver and silver oxide hybrid nanoparticles: A potential antimicrobial against multi drug-resistant Pseudomonas aeruginosa. New. J. Chem. 2020, 44, 4935–4941. [Google Scholar] [CrossRef]
  80. Salvadori, M.; Monezi, T.; Mehnert, D.; Corrêa, B. Antimicrobial Activity of Ag/Ag2O Nanoparticles Synthesized by Dead Biomass of Yeast and their Biocompatibility with Mammalian Cell Lines. Int. J. Res. Stud. Microbiol. Biotechnol. 2019, 5, 2454–9428. [Google Scholar] [CrossRef]
  81. Kayed, K.; Mansour, G. The Antimicrobial Activity of Silver Nanoparticles in Ag/Ag2O Composites Synthesized by Oxygen Plasma Treatment of Silver Thin Films. Curr. Appl. Sci. Technol. 2022, 22, 9. [Google Scholar] [CrossRef]
  82. Akbari, Z.; Rashidi Ranjbar, Z.; Khaleghi, M. Synthesis, characterization, and antibacterial activities of Ag2O nanoparticle and silver (I) nano-rod complex. Nanochemistry Res. 2020, 5, 233–240. [Google Scholar]
  83. Rashmi, B.N.; Harlapur, S.F.; Avinash, B.; Ravikumar, C.R.; Nagaswarupa, H.P.; Anil Kumar, M.R.; Gurushantha, K.; Santosh, M.S. Facile green synthesis of silver oxide nanoparticles and their electrochemical, photocatalytic and biological studies. Inorg. Chem. Commun. 2020, 111, 107580. [Google Scholar] [CrossRef]
  84. Phongtongpasuk, S.; Poadang, S.; Yongvanich, N. Environmental-friendly Method for Synthesis of Silver Nanoparticles from Dragon Fruit Peel Extract and their Antibacterial Activities. Energy Procedia 2016, 89, 239–247. [Google Scholar] [CrossRef]
  85. Aisida, S.; Ugwu, K.; Nwanya, A.; Bashir, A.K.H.; Nwankwo, U.; Ahmed, I.; Ezema, F. Biosynthesis of silver oxide nanoparticles using leave extract of Telfairia Occidentalis and its antibacterial activity. Mater. Today Proc. 2021, 36, 208–213. [Google Scholar] [CrossRef]
  86. Kiani, F.A.; Shamraiz, U.; Badshah, A.; Tabassum, S.; Ambreen, M.; Patujo, J.A. Optimization of Ag2O nanostructures with strontium for biological and therapeutic potential. Artif. Cells Nanomed. Biotechnol. 2018, 46 (Suppl. S3), S1083–S1091. [Google Scholar] [CrossRef]
  87. Elyamny, S.; Eltarahony, M.; Abu-Serie, M.; Nabil, M.M.; Kashyout, A.E.-H.B. One-pot fabrication of Ag @Ag2O core–shell nanostructures for biosafe antimicrobial and antibiofilm applications. Sci. Rep. 2021, 11, 22543. [Google Scholar] [CrossRef]
  88. Gudkov, S.V.; Burmistrov, D.E.; Serov, D.A.; Rebezov, M.B.; Semenova, A.A.; Lisitsyn, A.B. Do Iron Oxide Nanoparticles Have Significant Antibacterial Properties? Antibiotics 2021, 10, 884. [Google Scholar] [CrossRef] [PubMed]
  89. Arias, L.S.; Pessan, J.P.; Vieira, A.P.M.; Lima, T.M.T.D.; Delbem, A.C.B.; Monteiro, D.R. Iron oxide nanoparticles for biomedical applications: A perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics 2018, 7, 46. [Google Scholar] [CrossRef] [PubMed]
  90. Apopa, P.L.; Qian, Y.; Shao, R.; Guo, N.L.; Schwegler-Berry, D.; Pacurari, M.; Porter, D.; Shi, X.; Vallyathan, V.; Castranova, V. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part. Fibre Toxicol. 2009, 6, 1. [Google Scholar] [CrossRef] [PubMed]
  91. Gong, Y.; Ji, Y.; Liu, F.; Li, J.; Cao, Y. Cytotoxicity, oxidative stress and inflammation induced by ZnO nanoparticles in endothelial cells: Interaction with palmitate or lipopolysaccharide. J. Appl. Toxicol. 2017, 37, 895–901. [Google Scholar] [CrossRef]
  92. Chatterjee, N.; Walker, G.C. Mechanisms of DNA damage, repair, and mutagenesis. Env. Mol Mutagen 2017, 58, 235–263. [Google Scholar] [CrossRef]
  93. Doolittle, W.F. A paradigm gets shifty. Nature 1998, 392, 15–16. [Google Scholar] [CrossRef]
  94. Wigley, D.B. Bacterial DNA repair: Recent insights into the mechanism of RecBCD, AddAB and AdnAB. Nat. Rev. Microbiol. 2013, 11, 9–13. [Google Scholar] [CrossRef]
  95. Torabi, S.; Mansoorkhani, M.J.K.; Majedi, A.; Motevalli, S. REVIEW: Synthesis, Medical and Photocatalyst Applications of Nano-Ag2O. J. Coord. Chem. 2020, 73, 1861–1880. [Google Scholar] [CrossRef]
  96. Sullivan, K.T.; Wu, C.; Piekiel, N.W.; Gaskell, K.; Zachariah, M.R. Synthesis and reactivity of nano-Ag2O as an oxidizer for energetic systems yielding antimicrobial products. Combust. Flame 2013, 160, 438–446. [Google Scholar] [CrossRef]
  97. Phan, C.M.; Nguyen, H.M. Role of Capping Agent in Wet Synthesis of Nanoparticles. J. Phys. Chem. A 2017, 121, 3213–3219. [Google Scholar] [CrossRef]
  98. Yong, N.L.; Ahmad, A.; Mohammad, A.W. Synthesis and characterization of silver oxide nanoparticles by a novel method. Int. J. Sci. Eng. Res. 2013, 4, 155–158. [Google Scholar]
  99. Jeung, D.-G.; Lee, M.; Paek, S.-M.; Oh, J.-M. Controlled Growth of Silver Oxide Nanoparticles on the Surface of Citrate Anion Intercalated Layered Double Hydroxide. Nanomaterials 2021, 11, 455. [Google Scholar] [CrossRef]
  100. Harish, K.; Manisha, K. Synthesis and characterization of silveroxide nanoparticles by sol-gel method. Int. J. Adv. Res. Sci. Eng. 2018, 7, 632–637. [Google Scholar]
  101. Wang, G.; Ma, X.; Huang, B.; Cheng, H.; Wang, Z.; Zhan, J.; Qin, X.; Zhang, X.; Dai, Y. Controlled synthesis of Ag 2 O microcrystals with facet-dependent photocatalytic activities. J. Mater. Chem. 2012, 22, 21189–21194. [Google Scholar] [CrossRef]
  102. Murray, B.; Li, Q.; Newberg, J.; Menke, E.; Hemminger, J.; Penner, R. Shape-and size-selective electrochemical synthesis of dispersed silver (I) oxide colloids. Nano Lett. 2005, 5, 2319–2324. [Google Scholar] [CrossRef]
  103. Saha, S.; Chattopadhyay, D.; Acharya, K. Preparation of silver nanoparticles by bio-reduction using nigrospora oryzae culture filtrate and its antimicrobial activity. Dig. J. Nanomater. Biostructures (DJNB) 2011, 6, 1842–3582. [Google Scholar]
  104. Ponnuchamy, K.; Selvi, S.; Prabha, L.; Premkumar, K.; Ganeshkumar, R.; Munisamy, G. Synthesis of Silver Nanoparticles from Sargassum Tenerrimum and Screening Phytochemicals for Its Antibacterial Activity. Nano Biomed. Eng. 2012, 4, 12–16. [Google Scholar] [CrossRef]
  105. Maiti, S.; Krishnan, D.; Barman, G.; Ghosh, S.K.; Laha, J.K. Antimicrobial activities of silver nanoparticles synthesized from Lycopersicon esculentum extract. J. Anal. Sci. Technol. 2014, 5, 40. [Google Scholar] [CrossRef]
  106. Antony, E.; Sathiavelu, M.; Arunachalam, S. Synthesis of silver nanoparticles from the medicinal plant bauhinia acuminata and biophytum sensitivum–a comparative study of its biological activities with plant extract. Int. J. Appl. Pharm. 2016, 9, 22. [Google Scholar] [CrossRef]
  107. Mohamed, H.E.A.; Afridi, S.; Khalil, A.T.; Zia, D.; Iqbal, J.; Ullah, I.; Shinwari, Z.K.; Maaza, M. Biosynthesis of silver nanoparticles from Hyphaene thebaica fruits and their in vitro pharmacognostic potential. Mater. Res. Express 2019, 6, 1050c9. [Google Scholar] [CrossRef]
  108. Kahsay, M.H.; Ramadevi, D.; Kumar, Y.P.; Mohan, B.S.; Tadesse, A.; Battu, G.; Basavaiah, K. Synthesis of silver nanoparticles using aqueous extract of Dolichos lablab for reduction of 4-Nitrophenol, antimicrobial and anticancer activities. OpenNano 2018, 3, 28–37. [Google Scholar] [CrossRef]
  109. Laouini, S.E.; Bouafia, A.; Soldatov, A.V.; Algarni, H.; Tedjani, M.L.; Ali, G.A.M.; Barhoum, A. Green Synthesized of Ag/Ag(2)O Nanoparticles Using Aqueous Leaves Extracts of Phoenix dactylifera L. and Their Azo Dye Photodegradation. Membranes 2021, 11, 468. [Google Scholar] [CrossRef]
  110. Gomaa, E.Z. Silver nanoparticles as an antimicrobial agent: A case study on Staphylococcus aureus and Escherichia coli as models for Gram-positive and Gram-negative bacteria. J. Gen. Appl. Microbiol. 2017, 63, 36–43. [Google Scholar] [CrossRef]
  111. Gurunathan, S.; Kalishwaralal, K.; Vaidyanathan, R.; Venkataraman, D.; Pandian, S.R.K.; Muniyandi, J.; Hariharan, N.; Eom, S.H. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli. Colloids Surf. B Biointerfaces 2009, 74, 328–335. [Google Scholar] [CrossRef] [PubMed]
  112. Rao, K.; Imran, M.; Jabri, T.; Ali, I.; Perveen, S.; Shafiullah; Ahmed, S.; Shah, M.R. Gum tragacanth stabilized green gold nanoparticles as cargos for Naringin loading: A morphological investigation through AFM. Carbohydr. Polym. 2017, 174, 243–252. [Google Scholar] [CrossRef] [PubMed]
  113. Song, Z.; Hrbek, J.; Osgood, R. Formation of TiO2 nanoparticles by reactive-layer-assisted deposition and characterization by XPS and STM. Nano Lett. 2005, 5, 1327–1332. [Google Scholar] [CrossRef] [PubMed]
  114. Nagajyothi, P.C.; Sreekanth, T.V.; Tettey, C.O.; Jun, Y.I.; Mook, S.H. Characterization, antibacterial, antioxidant, and cytotoxic activities of ZnO nanoparticles using Coptidis Rhizoma. Bioorganic Med. Chem. Lett. 2014, 24, 4298–4303. [Google Scholar] [CrossRef]
  115. Mittal, A.K.; Chisti, Y.; Banerjee, U.C. Synthesis of metallic nanoparticles using plant extracts. Biotechnol. Adv. 2013, 31, 346–356. [Google Scholar] [CrossRef]
  116. Wang, T.; Lin, J.; Chen, Z.; Megharaj, M.; Naidu, R. Green synthesized iron nanoparticles by green tea and eucalyptus leaves extracts used for removal of nitrate in aqueous solution. J. Clean. Prod. 2014, 83, 413–419. [Google Scholar] [CrossRef]
  117. Rauwel, P.; Küünal, S.; Ferdov, S.; Rauwel, E. A Review on the Green Synthesis of Silver Nanoparticles and Their Morphologies Studied via TEM. Adv. Mater. Sci. Eng. 2015, 2015, 682749. [Google Scholar] [CrossRef]
  118. Singh, V.; Shrivastava, A.; Wahi, N. Biosynthesis of silver nanoparticles by plants crude extracts and their characterization using UV, XRD, TEM and EDX. Afr. J. Biotechnol. 2015, 14, 2554–2567. [Google Scholar] [CrossRef]
  119. Naraginti, S.; Li, Y. Preliminary investigation of catalytic, antioxidant, anticancer and bactericidal activity of green synthesized silver and gold nanoparticles using Actinidia deliciosa. J. Photochem. Photobiol. B Biol. 2017, 170, 225–234. [Google Scholar] [CrossRef]
  120. Sana, S.S.; Dogiparthi, L.K. Green synthesis of silver nanoparticles using Givotia moluccana leaf extract and evaluation of their antimicrobial activity. Mater. Lett. 2018, 226, 47–51. [Google Scholar] [CrossRef]
  121. Monshi, A.; Foroughi, M.; Monshi, M. Modified Scherrer Equation to Estimate More Accurately Nano-Crystallite Size Using XRD. World J. Nano Sci. Eng. 2012, 2, 154–160. [Google Scholar] [CrossRef]
  122. Zad, Z.R.; Davarani, S.S.H.; Taheri, A.; Bide, Y. A yolk shell Fe3O4@ PA-Ni@ Pd/Chitosan nanocomposite-modified carbon ionic liquid electrode as a new sensor for the sensitive determination of fluconazole in pharmaceutical preparations and biological fluids. J. Mol. Liq. 2018, 253, 233–240. [Google Scholar] [CrossRef]
  123. Das, B.; Dash, S.K.; Mandal, D.; Ghosh, T.; Chattopadhyay, S.; Tripathy, S.; Das, S.; Dey, S.K.; Das, D.; Roy, S. Green synthesized silver nanoparticles destroy multidrug resistant bacteria via reactive oxygen species mediated membrane damage. Arab. J. Chem. 2017, 10, 862–876. [Google Scholar] [CrossRef]
  124. Surma, N.; Ijuo, G.; Ogoh-Orch, B. Fuel Gases from Waste High Density Polyethylene (Hdpe) Via Low Temperature Catalytic Pyrolysis. Prog. Chem. Biochem. Res. 2020, 3, 20–30. [Google Scholar] [CrossRef]
  125. Venkateswarlu, S.; Natesh Kumar, B.; Prasad, C.H.; Venkateswarlu, P.; Jyothi, N.V.V. Bio-inspired green synthesis of Fe3O4 spherical magnetic nanoparticles using Syzygium cumini seed extract. Phys. B Condens. Matter 2014, 449, 67–71. [Google Scholar] [CrossRef]
  126. Astashev, M.E.; Sarimov, R.M.; Serov, D.A.; Matveeva, T.A.; Simakin, A.V.; Ignatenko, D.N.; Burmistrov, D.E.; Smirnova, V.V.; Kurilov, A.D.; Mashchenko, V.I.; et al. Antibacterial behavior of organosilicon composite with nano aluminum oxide without influencing animal cells. React. Funct. Polym. 2022, 170, 105143. [Google Scholar] [CrossRef]
  127. Von Naegelli, V. Silver nitrate: A very effective antimicrobial agent. Deut. Schr. Schweiz Nat. Ges 1893, 33, 174–182. [Google Scholar]
  128. Raffi, M.; Hussain, F.; Bhatti, T.; Akhter, J.; Hameed, A.; Hasan, M. Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224. J. Mater. Sci. Technol. 2008, 24, 192–196. [Google Scholar]
  129. Sondi, I.; Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 2004, 275, 177–182. [Google Scholar] [CrossRef]
  130. Belly, R.T.; Kydd, G.C. Silver resistance in microorganisms. Dev. Ind. Microbiol. 1982, 23, 567–578. [Google Scholar]
  131. Grigor’eva, A.; Saranina, I.; Tikunova, N.; Safonov, A.; Timoshenko, N.; Rebrov, A.; Ryabchikova, E. Fine mechanisms of the interaction of silver nanoparticles with the cells of Salmonella typhimurium and Staphylococcus aureus. Biometals Int. J. Role Met. Ions Biol. Biochem. Med. 2013, 26, 479–488. [Google Scholar] [CrossRef]
  132. Song, H.; Ko, K.; Oh, L.; Lee, B. Fabrication of silver nanoparticles and their antimicrobial mechanisms. Eur. Cells Mater. 2006, 11 (Suppl. S1), 58. [Google Scholar]
  133. Sambhy, V.; Macbride, M.M.; Peterson, B.R.; Sen, A. Silver bromide nanoparticle/polymer composites: Dual action tunable antimicrobial materials. J. Am. Chem. Soc. 2006, 128, 9798–9808. [Google Scholar] [CrossRef]
  134. Russell, A.D.; Hugo, W.B. 7 Antimicrobial Activity and Action of Silver Periodical 7 Antimicrobial Activity and Action of Silver [Online]. 1994, pp. 351–370. Available online: https://www.sciencedirect.com/science/article/pii/S0079646808700249 (accessed on 25 April 2022). [CrossRef]
  135. Xia, T.; Kovochich, M.; Brant, J.; Hotze, M.; Sempf, J.; Oberley, T.; Sioutas, C.; Yeh, J.I.; Wiesner, M.R.; Nel, A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6, 1794–1807. [Google Scholar] [CrossRef]
  136. Bruskov, V.I.; Karp, O.E.; Garmash, S.A.; Shtarkman, I.N.; Chernikov, A.V.; Gudkov, S.V. Prolongation of oxidative stress by long-lived reactive protein species induced by X-ray radiation and their genotoxic action. Free Radic. Res. 2012, 46, 1280–1290. [Google Scholar] [CrossRef]
  137. Bruskov, V.I.; Malakhova, L.V.; Masalimov, Z.K.; Chernikov, A.V. Heat-induced formation of reactive oxygen species and 8-oxoguanine, a biomarker of damage to DNA. Nucleic Acids Res. 2002, 30, 1354–1363. [Google Scholar] [CrossRef]
  138. Burmistrov, D.E.; Simakin, A.V.; Smirnova, V.V.; Uvarov, O.V.; Ivashkin, P.I.; Kucherov, R.N.; Ivanov, V.E.; Bruskov, V.I.; Sevostyanov, M.A.; Baikin, A.S.; et al. Bacteriostatic and Cytotoxic Properties of Composite Material Based on ZnO Nanoparticles in PLGA Obtained by Low Temperature Method. Polymers 2022, 14, 49. [Google Scholar] [CrossRef]
  139. Ocsoy, I.; Paret, M.L.; Ocsoy, M.A.; Kunwar, S.; Chen, T.; You, M.; Tan, W. Nanotechnology in Plant Disease Management: DNA-Directed Silver Nanoparticles on Graphene Oxide as an Antibacterial against Xanthomonas perforans. ACS Nano 2013, 7, 8972–8980. [Google Scholar] [CrossRef]
  140. Allahverdiyev, A.M.; Abamor, E.S.; Bagirova, M.; Rafailovich, M. Antimicrobial effects of TiO2 and Ag2O nanoparticles against drug-resistant bacteria and leishmania parasites. Future Microbiol. 2011, 6, 933–940. [Google Scholar] [CrossRef]
  141. Hua, H.; Xi, Y.; Zhao, Z.; Xie, X.; Hu, C.; Liu, H. Gram-scale wet chemical synthesis of Ag2O/TiO2 aggregated sphere heterostructure with high photocatalytic activity. Mater. Lett. 2013, 91, 81–83. [Google Scholar] [CrossRef]
  142. Wu, C.; Shen, L.; Cai Zhang, Y.; Huang, Q. Solvothermal synthesis of Ag/ZnO nanocomposite with enhanced photocatalytic activity. Mater. Lett. 2013, 106, 104–106. [Google Scholar] [CrossRef]
  143. Fernandez, C.; Thomas, A.; M, S. Green synthesis of silver oxide nanoparticle and its antimicrobial activity against organisms causing Dental plaques. Int. J. Pharma. Bio. Sci. 2016, 7, 14–19. [Google Scholar] [CrossRef]
  144. Bai, X.; Li, L.; Liu, H.; Tan, L.; Liu, T.; Meng, X. Solvothermal Synthesis of ZnO Nanoparticles and Anti-Infection Application in Vivo. ACS Appl. Mater. Interfaces 2015, 7, 1308–1317. [Google Scholar] [CrossRef] [PubMed]
  145. Salvadori, M.R.; Ando, R.A.; Nascimento, C.A.O.; Corrêa, B. Dead biomass of Amazon yeast: A new insight into bioremediation and recovery of silver by intracellular synthesis of nanoparticles. J. Environ. Sci. Health Part A 2017, 52, 1112–1120. [Google Scholar] [CrossRef]
  146. Vinay, S.P.; Udayabhanu; Nagaraju, G.; Chandrappa, C.P.; Chandrasekhar, N. Rauvolfia tetraphylla (Devil Pepper)-Mediated Green Synthesis of Ag Nanoparticles: Applications to Anticancer, Antioxidant and Antimitotic. J. Clust. Sci. 2019, 30, 1545–1564. [Google Scholar] [CrossRef]
  147. Fard, N.N.; Noorbazargan, H.; Mirzaie, A.; Hedayati Ch, M.; Moghimiyan, Z.; Rahimi, A. Biogenic synthesis of AgNPs using Artemisia oliveriana extract and their biological activities for an effective treatment of lung cancer. Artif. Cells Nanomed. Biotechnol. 2018, 46 (Suppl. S3), S1047–S1058. [Google Scholar] [CrossRef]
  148. Schlinkert, P.; Casals, E.; Boyles, M.; Tischler, U.; Hornig, E.; Tran, N.; Zhao, J.; Himly, M.; Riediker, M.; Oostingh, G.J.; et al. The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell types. J. Nanobiotechnol. 2015, 13, 1. [Google Scholar] [CrossRef]
  149. Guo, C.; Buckley, A.; Marczylo, T.; Seiffert, J.; Römer, I.; Warren, J.; Hodgson, A.; Chung, K.F.; Gant, T.W.; Smith, R.; et al. The small airway epithelium as a target for the adverse pulmonary effects of silver nanoparticle inhalation. Nanotoxicology 2018, 12, 539–553. [Google Scholar] [CrossRef]
  150. Yeasmin, S.; Datta, H.K.; Chaudhuri, S.; Malik, D.; Bandyopadhyay, A. In-vitro anti-cancer activity of shape controlled silver nanoparticles (AgNPs) in various organ specific cell lines. J. Mol. Liq. 2017, 242, 757–766. [Google Scholar] [CrossRef]
  151. Miyayama, T.; Fujiki, K.; Matsuoka, M. Silver nanoparticles induce lysosomal-autophagic defects and decreased expression of transcription factor EB in A549 human lung adenocarcinoma cells. Toxicol. Vitr. Int. J. Publ. Assoc. BIBRA 2018, 46, 148–154. [Google Scholar] [CrossRef]
  152. Akter, M.; Sikder, M.T.; Rahman, M.M.; Ullah, A.; Hossain, K.F.B.; Banik, S.; Hosokawa, T.; Saito, T.; Kurasaki, M. A systematic review on silver nanoparticles-induced cytotoxicity: Physicochemical properties and perspectives. J. Adv. Res. 2018, 9, 1–16. [Google Scholar] [CrossRef]
  153. González-Vega, J.G.; García-Ramos, J.C.; Chavez-Santoscoy, R.A.; Castillo-Quiñones, J.E.; Arellano-Garcia, M.E.; Toledano-Magaña, Y. Lung Models to Evaluate Silver Nanoparticles’ Toxicity and Their Impact on Human Health. Nanomaterials 2022, 12, 2316. [Google Scholar] [CrossRef]
  154. García, M.C.; Torres, J.; Dan Córdoba, A.V.; Longhi, M.; Uberman, P.M. Drug delivery using metal oxide nanoparticles Periodical Drug delivery using metal oxide nanoparticles [Online]. 2022, pp. 35–83. Available online: https://www.sciencedirect.com/science/article/pii/B9780128230336000296 (accessed on 8 May 2022). [CrossRef]
  155. Qureshi, A.T. Silver Nanoparticles as Drug Delivery Systems. LSU Dr. Diss. 2013, 1069. [Google Scholar] [CrossRef]
  156. Ghiuță, I.; Cristea, D. Silver nanoparticles for delivery purposes. In Nanoengineered Biomaterials for Advanced Drug Delivery; Mozafari, M., Ed.; Elsevier: Amsterdam, The Netherlands, 2020; pp. 347–371. [Google Scholar] [CrossRef]
  157. Zhang, X.F.; Gurunathan, S. Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: An effective anticancer therapy. Int. J. Nanomed. 2016, 11, 3655–3675. [Google Scholar] [CrossRef]
  158. Yuan, Y.G.; Peng, Q.L.; Gurunathan, S. Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: Combination therapy for effective cancer treatment. Int. J. Nanomed. 2017, 12, 6487–6502. [Google Scholar] [CrossRef]
  159. Baram-Pinto, D.; Shukla, S.; Perkas, N.; Gedanken, A.; Sarid, R. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjugate Chem. 2009, 20, 1497–1502. [Google Scholar] [CrossRef]
  160. Ivanova, N.; Gugleva, V.; Dobreva, M.; Pehlivanov, I.; Stefanov, S.; Andonova, V. Silver Nanoparticles as Multi-Functional Drug Delivery Systems; IntechOpen: London, UK, 2019; pp. 71–91. [Google Scholar] [CrossRef]
Pharmaceuticals 15 00968 g001 550
Figure 1. Results of the data analysis regarding antimicrobial properties of Ag2O NPs: (a) microorganisms, against which the inhibitory activity of NPs was shown most often; (b) dependence of MIC against E. coli on NP sizes. R—value of the correlation coefficient; (c) dependence of MIC on a method of NP generation. *—p < 0.05, a significant difference from the precipitation variant using the Mann–Whitney test. Each dot represents a mention in one publication. The data are presented as medians, percentiles (10, 25, 75 and 90%).
Figure 1. Results of the data analysis regarding antimicrobial properties of Ag2O NPs: (a) microorganisms, against which the inhibitory activity of NPs was shown most often; (b) dependence of MIC against E. coli on NP sizes. R—value of the correlation coefficient; (c) dependence of MIC on a method of NP generation. *—p < 0.05, a significant difference from the precipitation variant using the Mann–Whitney test. Each dot represents a mention in one publication. The data are presented as medians, percentiles (10, 25, 75 and 90%).
Pharmaceuticals 15 00968 g001
Pharmaceuticals 15 00968 g002 550
Figure 2. Schematic representation of mechanisms of the antibacterial activity of Ag2O NPs (explanations are given in the text).
Figure 2. Schematic representation of mechanisms of the antibacterial activity of Ag2O NPs (explanations are given in the text).
Pharmaceuticals 15 00968 g002
Table
Table 1. Antimicrobial properties of Polymers/Ag2O nanocomposites.
Table 1. Antimicrobial properties of Polymers/Ag2O nanocomposites.
№CompositionParticle Size, nmMicroorganism StrainsEffectMIC/MBCResultsReference
1Ag2O NPs coating on glass~1500Pseudomonas aeruginosa (DSM-9644),
Staphylococcus aureus (ATCC no. 6538),
Staphylococcus aureus (MA43300 methicillin-resistant),
SARS-CoV-2 virus		Bacteriostatic
Bactericidal
Antiviral		1.18 mg/mLCoating of glass surfaces with Ag2O NPs significantly reduced the titers of the SARS-CoV-2 virus on the treated surface after 1 and 24 h. Ag2O NPs caused the death of all studied bacteria after 1 h. The activities against Gram-negative bacteria were more pronounced.[13]
2AgO NPs~170Staphylococcus aureusBactericidal20 µg/mLThe bactericidal action of AgO NPs realized via disruption of the bacterial cell wall integrity detectable by K+ leakage from cells, increased Ag content in cell walls and TEM data.[19]
3Ag2O NPs in Ag2O NPs/Ag sensor for detection of 4-nitrotoluene80–90Escherichia coli,
Staphylococcus aureus		Bacteriostatic100 µg/mLAg2O NPs showed bacteriostatic effect against both studied bacteria. The antimicrobial effect against Gram-positive bacteria is much higher.[22]
4Ag2O NPs synthesized in Aspergillus terreus VIT 2013 culture500–1000
(TEM images)		Staphylococcus aureus methicillin resistant Bacteriostatic~23.2 mg/mL *
(0.1 mM Ag2O)		Ag2O NPs inhibited growth of all studied antibiotic-resistant S. aureus strains.[27]
5Ag2O NPs synthesized in Rhamnus virgate extracts110–120Aspergillus flavus,
Aspergillus niger,
Bacillus subtilis,
Candida albicans,
Escherichia coli,
Fusarium solani,
Klebsiella pneumonia,
Mucor racemosus,
Pseudomonas aeruginosa,
Staphylococcus aureus		Bacteriostatic
Fungistatic		28.125–112.5 µg/mLAntimicrobial activity significantly varied depending on the species of microorganism. Ag2O NPs decreased viability of HepG2 cell line and HUH-7 cancer cells at concentrations above 9 µg/mL.
Using of ethanol extract to Ag2O NPs synthesis increased their antimicrobial activity.		[33]
6Ag2O NPs synthesized in Pinus longifolia extract1–100Bacillus subtilis,
Escherichia coli,
Staphylococcus aureus		Bacteriostatic25 µg/mLAg2O NPs/P. longifolia inhibited the growth of both Gram-positive and Gram-negative bacteria equally[34]
7Ag2O NPs synthesized in Paeonia emodi extract38–86Bacillus subtilis,
Escherichia coli,
Pseudomonas aeruginosa,
Staphylococcus aureus		Bacteriostatic0.125 µg/mLBacteriostatic action against Gram-negative bacteria was more pronounced. The mechanism of bacteriostatic action is a photocatalysis.[35]
8Ag2O NPs synthesized in Cyathea nilgiriensis extract8–40Bacillus subtilis,
Escherichia coli,
Klebsiella pneumonia,
Micrococcus luteus,
Salmonella paratyphi,
Staphylococcus aureus,
Aspergillus niger,
Candida albicans		Bacteriostatic
Fungistatic		~100 µg/mLAg2O NPs/C. nilgiriensis showed bacteriostatic, antifungal and antitumor activity.[36]
9Natural hydrogel from Abroma augusta/Ag-Ag2O NP with varying polyphenol concentrations of 50, 100, 150 and 200 μg/mL20–40Bacillus cereus MTCC 430,
C. albicans MTCC 227,
Escherichia coli MTCC 443,
Klebsiella pneumoniae MTCC 7162,
Pseudomonas aeruginosa MTCC 741,
Staphylococcus aureus MTCC 96		Bacteriostatic
Bactericidal
Fungicidal		12.5/25 µg/mL
12.5/25 µg/mL
25/50 µg/mL
25/50 µg/mL
25/50 µg/mL		Maximal antimicrobial effect of nanocomposite was observed at 200 μg/mL polyphenol concentrations.[37]
10Ag2O NPs mixed with chitosan solution (1% w/v in 1% acetic acid) and dried~5 №~5.8 mg/mL
(stock 0.1 M AgNO3, was used [38]; 0.05 M Ag2O was synthesized and diluted twice to 0.025 M) 		Chitosan/Ag2O NPs inhibited growth of all studied bacteria.[39]
11Chitosan/Ag2O NPs suspension10–20 Escherichia coli,
Staphylococcus aureus		Bacteriostatic2 µg/mLTreating of cotton fibers by chitosan/Ag2O NPs suspension reduced Gram-negative and Gram-positive bacterial growth up to 100%.[40]
12Chitosan/Ag2O NPs suspension100–200Escherichia coli,
Staphylococcus aureus		Bacteriostatic2 µg/mLTreating of cotton fibers by chitosan/Ag2O NPs suspension reduced bacterial growth and did not change coefficient of friction of the treated fabric.[41]
13Polyethersulfone (PES)/cellulose acetate (CA)/Ag2O NPs nanocomposite and Cu·PES/CA/Ag2O NP membranes20–100Escherichia coliBacteriostatic8 mg/mLPES/CA/Ag2O NPs and Cu·PES/CA/Ag2O NPs composites inhibited bacterial growth up to 20–30 and 80–90%, respectively, during 12–24 h.[42]
14Aspirin conjugated Ag2O NPs coated by polyvinyl alcohol (PVA) or starch-Apergillus niger,
Citrobacter freundii,
Curvularia lunata,
Enterobacter aerogenes,
Escherichia coli,
Proteus vulgaris,
Staphylococcus aureus,
Vibrio cholera,
Helmentiasporium maydis,
Paecilomyces lilacinusby,
Rhizopus nigricans		Bacteriostatic,
Fungistatic		10 µg/mLAspirin conjugated Ag2O NPs inhibited microbial growth above 40%. Coating of Aspirin/Ag2O NP by PVA or starch increased percent inhibition to 60%.[43]
15Bayerite underpinned Ag2O/Ag NPs incorporated PMMA films-Acinetobactor baumannii C78 and C80,
Pseudomonas aeruginosa RRLP1 and RRLP2		Bacteriostatic0.034 and 0.017 mg/mLBayerite Ag2O/Ag nanohybrid demonstrated antibacterial and antibiofilm activities against tested standard strains and clinical isolates.[44]
16Graphene oxide (GO)/Ag2O NPs composite36.3–49.9Escherichia coli,
Staphylococcus aureus		Bacteriostatic20 mg/mLGO/Ag2O NPs composite was more effective against Gram-negative bacteria. Increasing of GO wt% improved bacteriostatic activity of nanocomposite.[45]
17Polyethylene terephthalate (PET)/Ag2O NPs composite50–500Escherichia coliBacteriostatic-PET/Ag2O NPs inhibited bacterial growth. Bacteriostatic was same in PET/Ag2O NPs samples obtained at different pH.[46]
18Ag2O-TiO2 NPs50–150Escherichia coliBacteriostatic1.5 mg/mLThe nanocomposite increased photocatalytic degradation of aniline and inhibit E. coli growth.[47]
19Ag2O-TiO2 NPs immobilized on doped by cellulose10 ± 5-Proposed bactericidal by photocatalysis-The nanocomposite increased photocatalytic degradation of methylene blue, Rhodamine B and norfloxacin under the irradiation of UV light.[48]
20Ag2O NPs synthesized with culture Bacillus paramycoides 28–38Enterobacter sp.,
Micrococcus sp.
Salmonella sp.,
Vibrio parahaemolyticus		Bactericidal20 µg/mLAg2O NPs showed significant bactericidal and antibiofilm activity through bacterial binding. Ag2O NPs had cytotoxic action versus A549 cancer cell line.[49]
21Precipitated Ag2O NPs30Escherichia coliBacteriostatic
Bactericidal		30 µg/mL
40 µg/mL		Ag2O NPs almost completely inhibited the growth of E. coli and caused lysis of bacterial cells.[50]
22Green synthesized Ag2O NPs with Lawsonia inermis extract~39Aspergillus sp.,
Candida albicans,
Escherichia coli,
Penicillium sp.,
Pseudomonas aeruginosa,
Staphylococcus aureus		Bacteriostatic
Fungistatic		23.1 µg/mL *
(MIC against Aspergillus sp was 0.1 M)		Ag2O NPs showed comparable bacteriostatic activity against Gram-positive and Gram-negative bacteria[51]
23Borosiloxane Ag2O NPs nanocomposite65Escherichia coliBacteriostatic
Bactericidal		1 µg/mLAg2O NPs doped into a borosiloxane matrix pronounced bacteriostatic and bactericidal properties via generation of ROS but did not have cytotoxicity against eukaryotic cells. [52]
24PLGA and Ag2O NPs nanocomposite35Escherichia coliBacteriostatic
Bactericidal		1 µg/mLAg2O NPs increased generation of H2O2 and OH-radicals, which can lead to damage to bacterial DNA and proteins but does not have cytotoxicity against mammalian cells.[53]
25Ag2O NPs in Bacillus thuringiensis SSV1 culture supernatant10–40Bacillus cereus,
Enterococcus faecalis,
Escherichia coli,
Proteus mirabilis,
Pseudomonas sp.,
Staphylococcus aureus		Bacteriostatic0.16 µg/mL“Green synthesized” Ag2O NPs shower a weak bacteriostatic effect against both Gram-positive and Gram-negative bacteria. Ag2O NPs, but not B. thuringiensis induced antimicrobial action.[54]
26ZrO2-Ag2O NPs14–42Bacillus subtilis,
Streptococcus mutans,
Escherichia coli,
Klebsiella oxytoca,
Pseudomonas aeruginosa,
Staphylococcus aureus		Bacteriostatic0.1 µg/mLZrO2 NPs enhanced the bacteriostatic effect of Ag2O NPs. The bacteriostatic effect of both Ag2O NPs and ZrO2-Ag2O depends more on the bacterial species than on belonging to Gram-positive and Gram-negative bacteria.[55]
27Ag2O/Ag NPs with Fusarium oxysporum components6–8Aspergillus niger,
Bacillus subtilis		Bacteriostatic
Fungistatic		50 µg/mLThe antibacterial action was realized via increased ROS generation[56]
28Ag2O NPs conjugated with starch in different proportions30–110Bacillus cereus,
Escherichia coli,
Listeria monocytogenes,
Proteus vulgaris,
Pseudomonas putida,
Salmonella typhymurium,
Staphylococcus aureus,
Staphylococcus saprophyticus		Bacteriostatic100 µg/mLThe bacteriostatic properties of starch-conjugated Ag2O NPs enhanced with increasing size and starch/Ag2O NPs ratio.[57]
29Ag2O NPs synthesized by precipitation method16Aeromonas hydrophila ATCC 7966TBacteriostatic60 µg/mLAg2O NPs starting at 60 µg/mL inhibited bacterial growth. CFU of A. hydrophila was not found on agar at concentrations of Ag2O NPs above 240 µg/mL. [58]
30Ag and Ag2O NPs synthesized by reduction of [Ag(NH3)2]+ and conjugated by different sugars25Enterococcus faecalis,
Escherichia coli,
Staphylococcus aureus,
Enterococcus faecium,
Klebsiella pneumonia ESBL-positive,
Pseudomonas aeruginosa methicillin-susceptible,
Pseudomonas aeruginosa,
Staphylococcus aureus
vancomycin-resistant,
Staphylococcus epidermidi
meithicillin-resistant,
Staphylococcus epidermidis
methicillin-resistant		Bacteriostatic
Bactericidal		0.68 µg/mLAg and Ag2O NPs showed more pronounced antimicrobial activity against Gram-negative bacteria. The addition of glucose and lactose to the NP synthesis medium significantly enhanced the antimicrobial effect of NPs.[59]
31Ag2O and Ag NPs synthesized using Ficus benghalensis extract42.7Lactobacilli sp.,
Streptococcus mutans		Bacteriostatic
Bactericidal		100 µg/mL/
150 µg/mL		Ag2O NPs equally inhibited the growth of the studied oral pathogens, regardless of Gram staining. Ficus benghalensis extract reduced MIC/MBC by 25% compared to Ag2O NPs without extract or silver salt solution[60]
32Ag2O NPs synthesized using Nitrobacter sp. (strain NCIM 5067) extract40Escherichia coli,
Klebsiella pneumonia,
Salmonella typhimurium,
Staphylococcus aureus		Bacteriostatic100 µg/mLAg2O NPs/Nitrobacter sp. extract inhibited the growth of both Gram-positive and Gram-negative bacteria equally. The degree of inhibition was comparable to the effects of streptomycin (100 µg/mL). Ag2O NPs/Nitrobacter sp. extract showed antioxidant properties.[61]
33Ag2O NPs conjugated with moxifloxacin49.76Aspergillus Niger,
Bacillus subtilis,
Candida albicans,
Escherichia coli,
Pseudomonas aeruginosa,
Staphylococcus aureus		Bacteriostatic
Fungistatic		40–60 µg/mL *
(initial 40–60 µl of suspension with 0.05 mg/mL)		The conjugation of Ag2O NPs with moxifloxacin increased the area of the zone of inhibition for all stufied microorganisms by 2–3 times compared to non-conjugated Ag2O NPs. The photocatalytic action is proposed mechanism of antimicrobial action.[62]
34Ag2O NPs conjugated with silk fibroin (Ag2O-SF)15Escherichia coli,
Mycobacterium tuberculosis,
Staphylococcus aureus		Bacteriostatic115.9 µg/mL *
(0.5 mM Ag2O)		The conjugation of Ag2O NPs with silk fibroin enhances the bacteriostatic properties of Ag2O NPs[63]
35Ag2O NPs composite with Lippia citriodora plant powder20Aspergillus aureus,
Staphylococcus aureus		Bacteriostatic
Fungistatic		0.1 mg/mLAg2O NPs/L. citriodora showed antibacterial and antifungal properties. Antibacterial activity was more pronounced and comparable to the activity of tetracycline.
Ag2O NPs/L. citriodora significantly accelerated wound healing in rats compared to Ag2O NPs or controls.		[64]
36Ag/Ag2O NPs with leaf extract of Eupatorium odoratum8.2–20.5Bacillus subtilis,
Candida albicans,
Escheerichua coli,
Salmonella typhi,
Staphylococcus aureus		Bacteriostatic
Fungistatic		25–75 µg/mL
100 µg/mL		Ag2O NPs/E. odoratum inhibited the growth of Gram-negative bacteria to a greater extent compared with Gram-positive and fungi.[65]
37Ag2O NPs with Cleome gynandra extract66Escheerichua coli,
Staphylococcus aureus		Bacteriostatic~4.2 mg/mL *
(20 µl suspension of 0.9 mM AgNO3)		Ag2O NPs/C. gynandra inhibited the growth of Gram-negative bacteria to a greater extent than Gram-positive ones[66]
38Highly or poorly oxidized AgO/Ag/SnO210–20Collectotrichum siamense strains BRSP08 and BRSP09,
Phytophthora cactorum,
Stenotrophomonas maltophilia,		Bacteriostatic
Fungistatic		0.4 µg/mL *
(10 µg/spot, spot is 40 µL)		Nanocomposites with highly oxidized AgO NPs had a more pronounced bacteriostatic effect, and composites of NPs with weakly oxidized AgO NPs had a more pronounced fungistatic effects.[67]
39Ag2O NPs17.45Bacillus aerius,
Bacillus circulans,
Escherichia coli,
Pseudomonas aeruginosa		Bacteriostatic
Bactericidal		5 µg/mL
7.5 µg/mL		Ag2O NPs had a more pronounced antibacterial effect against Gram-negative bacteria compared to Gram-positive ones. The mechanism of antibacterial action is inhibition of ATP synthesis.[68]
40Ag2O/Ag NPs synthesized in extract Aloe vera10–60Candida albicans,
Candida glabrata,
Candida parapsilopsis,
Escherichia coli,
Staphylococcus aureus		Bacteriostatic
Fungistatic		10 µg/mLAg2O/Ag NPs/Aloe vera inhibited the growth of Gram-negative bacteria to a greater extent than Gram-positive ones. Antimicrobial activity was comparable to 10 µg/mL carbenicillin or ampicillin. Antifungal action depended on the species of fungus. The most effective antimicrobial effect was show against C. parapsilopsi.[69]
41SrTiO3 nanotubes (NTs) embedded with Ag2O NTs10×80Staphylococcus aureusBactericidal―SrTiO3 NTs/Ag2O NPs inhibited the growth of S. aureus. The antimicrobial effect was realized due to Ag2O NPs.[70]
42Ag2O NPs/Ti NBs3–10Bacillus subtilisBactericidal100 µg/mLAg2O/Ti NPs reduced the number of B. subtilis CFU compared to the control. Light enhanced the antimicrobial properties of Ag2O/Ti NBs.[71]
43Ag2O NPs/Ti NBs5–30Escherichia coli,
Staphylococcus aureus		Bactericidal1.27 µg/mLAg2O NPs/Ti NBs killed 100% during 14–21 days. The release of Ag+ is the mechanism of its antibacterial action.[72]
44Ag2O/Ag NPs synthesized in Vaccinium arctostaphylos extract7–10Bacillus subtilis,
Escherichia coli,
Salmonella enteritidis,
Staphylococcus aureus		Bacteriostatic<116 µg/mL *
(amount of NPs synthesized from 1 mM of AgNO3)		The antimicrobial effect against Gram-positive bacteria is more pronounced than against Gram-negative ones.[73]
45Ag2O NPs with polyhedral shape400–700Escherichia coliBactericidal10 µg/mLThe antimicrobial effect of cubic NPs is two times higher than that of octahedral NPs.[74]
46H2Ti3O7•2H2O/Ag2O NPs nanocomposites 10–40Escherichia coli,
Bacillus subtilis		Bacteriostatic
Bactericidal		25 µg/mL
50 µg/mL		The addition of Ag2O NPs to H2Ti3O7·2H2O increased the antimicrobial properties. The antibacterial action was equal against Gram-negative and Gram-positive bacteria.[75]
47Ag/AgO/Ag2O NPs/Coleus aromaticus extract/reduced graphene oxide2–4Escherichia coli,
Klebsiella pneumonia,
Staphylococcus aureus		Bacteriostatic50 mg/mLAg/AgO/Ag2O NPs improved antimicrobial properties of resulting composite. The bacteriostatic effect against Gram-positive or Gram-negative bacteria was comparable.[76]
48Ceftriaxone/Ag2O NPs35.54Escherichia coliBacteriostatic
Bactericidal		10 µg/mLThe antimicrobial activities of ceftriaxone and Ag2O NPs, assessed by zones of inhibition, were summarized.[77]
49Ag/Ag2O NPs synthesized in Pseudomonas aeruginosa M6 extract without cells~10.4Escherichia coli,
Pseudomonas aeruginosa,
Staphylococcus aureus,
Candida albicans,
Candida glabrata,
Mycobacterium smegmatis		Bacteriostatic
Fungistatic		<12 µg/mL *
(100 µL suspension of P. aeruginosa M6 in 1 mM AgNO3/ml)		Antibacterial and antifungal activity significantly depended on the species of microorganisms. Interspecies differences in antibacterial action are more pronounced than differences between Gram-positive and Gram-negative bacteria.[78]
50Ag/Ag2O NPs synthesized in cell-free extract of Kitasatospora albolonga fungi20Pseudomonas aeruginosa multi drug resistantBacteriostatic125 µg/mLAg/Ag2O NPs had bacteriostatic effect and enhanced the antibacterial effect of 800 µg/mL carbenicillin.[79]
51Ag/Ag2O NPs synthesized in dead yeast Rhodotorula mucilaginosa biomass11Cryptococcus neoformans,
Escherichia coli multi-drug resistant,
Staphylococcus aureus		Bacteriostatic
Bactericidal
Fungistatic
Fungicidal		2 µg/mL
5 µg/mL
0.2 µg/mL
0.2 µg/mL		Ag/Ag2O NPs/R. mucilaginosa showed significant antibacterial and antifungal activity and moderate cytotoxicity against eukaryotic cell lines. Cytotoxic concentrations were 4–10 times higher than antimicrobial ones. NPs can be considered as a possible agent for the treatment of oncology.[80]
52Ag/Ag2O NPs synthesized in silver
films under oxygen plasma treatment
6–38Staphylococcus aureusBacteriostatic―The most bacteriostatic effect was shown by Ag2O NPs with smallest size. This NP were obtained at plasma power of 1250 W.[81]
53Ag2O NPs and nano-rod complex (1), [Ag (3-bpdh)(NO3)]n45–60Enterococcus faecalis,
Escherichia coli,
Pseudomonas aeruginosa,
Staphylococcus aureus		Bacteriostatic6.25–25 µg/mLAg2O NPs were equally effective against Gram-positive and Gram-negative bacteria. Least bacteriostatic effect against Escherichia coli (PTCC1330) was shown.[82]
54Ag2O NPs mixed with Centella Asiatica or Tridax sp. leaf powder11–12Aspergillus aureus,
Aspergillus fumigates,
Staphylococcus aureus,
Staphylococcus epidermidis		Bacteriostatic
Fungistatic		100 µg/mLAg2O NPs/Tridax had a more pronounced antimicrobial effect than Ag2O NPs/Centella. The mechanism of toxicity is photocatalytic activity.[83]
55Ag/Ag2O NPs synthesized in Hylocereus undatus extract25–26Escherichia coli,
Pseudomonas aeruginosa,
Staphylococus aureus		Bacteriostatic500 µg/mLAg2O NPs/H. undatus showed more strong bacteriostatic action against Gram-positive bacteria than against Gram-negative bacteria.[84]
56Ag2O NPs synthesized in Telfairia occidentalis extract8–10Klebsiella pneumoniaeBacteriostatic10 µg/mLAg2O NPs/T. occidentalis had persistent dose-dependent bacteriostatic effect.[85]
57Ag2O NPs with addition of 1–9% Sr35.7–48.4Enterobacter aerogens,
Bordetella bronchiseptaca,
Salmonella typhimurim,
Aspergillus fumigatus,
Aspergillus niger,
Fusarium soloni		Bacteriostatic
Fungistatic		~100 µg/mL
(100 μg/disc)		3% Sr/Ag2O NPs showed maximal bacteriostatic and fungistatic activities. Antibacterial activity did not depend on species. Antifungal activity was species dependent.[86]
58Ag2O/Ag NPs synthesized by precipitation of AgNO3 in N-propanol19–60Bacillus cereus,
Candida albicans
Chlorella vulgaris,
Enterococcus faecalis,
Pseudomonas aeruginosa,
Salmonella typhimurium,
Staphylococcus aureus		Bacteriostatic
Fungistatic		5 µg/mLAg2O/Ag NPs inhibited growth of all studied microbes, had anti-biofilm activity. Mechanism of toxicity is Ag+ releasing. Ag2O/Ag NPs showed less cytotoxicity against Vero cell line than equal amount of AgNO3.[87]
*—concentration is not directly indicated in article in µg/mL and is calculated based on description in Materials and Method sections. Original data are shown in brackets.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gudkov, S.V.; Serov, D.A.; Astashev, M.E.; Semenova, A.A.; Lisitsyn, A.B. Ag2O Nanoparticles as a Candidate for Antimicrobial Compounds of the New Generation. Pharmaceuticals 2022, 15, 968. https://doi.org/10.3390/ph15080968

AMA Style

Gudkov SV, Serov DA, Astashev ME, Semenova AA, Lisitsyn AB. Ag2O Nanoparticles as a Candidate for Antimicrobial Compounds of the New Generation. Pharmaceuticals. 2022; 15(8):968. https://doi.org/10.3390/ph15080968

Chicago/Turabian Style

Gudkov, Sergey V., Dmitriy A. Serov, Maxim E. Astashev, Anastasia A. Semenova, and Andrey B. Lisitsyn. 2022. "Ag2O Nanoparticles as a Candidate for Antimicrobial Compounds of the New Generation" Pharmaceuticals 15, no. 8: 968. https://doi.org/10.3390/ph15080968

APA Style

Gudkov, S. V., Serov, D. A., Astashev, M. E., Semenova, A. A., & Lisitsyn, A. B. (2022). Ag2O Nanoparticles as a Candidate for Antimicrobial Compounds of the New Generation. Pharmaceuticals, 15(8), 968. https://doi.org/10.3390/ph15080968

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop